The Competition Commission has confirmed it is actively investigating the South African subsidiary of the Indian generic drug manufacturer Hetero. They are looking into potential price collusion. This significant probe centres on the procurement of crucial HIV...
Ascendis Health has confirmed its plan to delist from the JSE in the first week of December, following an overwhelming mandate from its investors. This decision marks the culmination of the company’s significant turnaround strategy. Not long ago, it faced the...
The South African subsidiary of Indian generic giant Hetero has launched an urgent legal attack against the Department of Health over its latest HIV/AIDS drug tender. Hetero SA alleges that authorities unlawfully excluded it from crucial contracts to supply the...
Suspended Gauteng Department of Health (GDoH) head of department (HOD), Lesiba Malotana, suffered a significant blow. The Labour Court dismissed his urgent attempt to overturn his precautionary suspension. Gauteng Premier Panyaza Lesufi suspended Malotana as a...
As the diabetes crisis intensifies, civil society organisations are calling for President Cyril Ramaphosa to declare the disease a public health emergency. They are demanding urgent government intervention and dedicated resources to combat the disease’s...
